Drugs that contain Ertugliflozin

1. Drug name - STEGLATRO

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8080580 MERCK SHARP DOHME Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives
Jul, 2030

(7 years from now)

CN103497199B MERCK SHARP DOHME Dioxa-Bicyclo[3.2.1.]Octane-2,3,4-Triol Derivatives
Aug, 2029

(6 years from now)

CN102149717A MERCK SHARP DOHME Dioxa-Bicyclo[3.2.1.]Octane-2,3,4-Triol Derivatives
Aug, 2029

(6 years from now)

CN103497199A MERCK SHARP DOHME Dioxa-Bicyclo[3.2.1.]Octane-2,3,4-Triol Derivatives
Aug, 2029

(6 years from now)

CN102149717B MERCK SHARP DOHME Dioxa-Bicyclo [3.2.1]-2, 3, 4-Triol Derivatives
Aug, 2029

(6 years from now)

IN331468B MERCK SHARP DOHME Dioxabicyclo[ 3.2.1.]Octan E-2,3,4-Triol Derivatives,Dioxabicyclo( 3,2,1)Octan E-2,3,4-Triol Derivatives
Aug, 2029

(6 years from now)

EP2334687B1 MERCK SHARP DOHME Dioxa-Bicyclo[3.2.1.]Octane-2,3,4-Triol Derivatives
Aug, 2029

(6 years from now)

EP2334687B9 MERCK SHARP DOHME Dioxa-Bicyclo[3.2.1.]Octane-2,3,4-Triol Derivatives
Aug, 2029

(6 years from now)

EP2334687A1 MERCK SHARP DOHME Dioxa-Bicyclo[3.2.1.]Octane-2,3,4-Triol Derivatives
Aug, 2029

(6 years from now)

Treatment: NA

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
5MG TABLET;ORAL Prescription
15MG TABLET;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.